For the millions of heart attack patients who arrive with blockages in multiple coronary arteries, the question of how aggressively to treat non-culprit vessels has long divided cardiologists. A new randomized trial published in the New England Journal of Medicine offers the most rigorous evidence yet that the method used to identify which additional arteries to stent may fundamentally change patient outcomes — a finding that could reshape how interventional cardiologists approach one of cardiology's most consequential intraoperative decisions.
The trial evaluated functional coronary angiography — a physiologic assessment technique that measures pressure gradients across arterial lesions to determine their hemodynamic significance — as a guide for complete revascularization in patients presenting with ST-elevation myocardial infarction (STEMI) and multivessel disease. Rather than treating all visually significant stenoses or leaving non-culprit vessels untouched, the functional guidance approach selectively targets only those lesions confirmed to impair coronary blood flow. The study enrolled a substantial patient cohort and tracked hard cardiovascular endpoints including death, recurrent myocardial infarction, and unplanned revascularization over a meaningful follow-up window, demonstrating measurable differences in outcomes between the functionally guided and angiography-alone arms.
This work lands in a field already reshaped by trials like COMPLETE and FLOWER-MI, which collectively established that complete revascularization is superior to culprit-only treatment, yet left unresolved the optimal method for identifying which lesions warrant intervention. Functional assessment — using tools such as fractional flow reserve (FFR) or instantaneous wave-free ratio (iFR) — has strong mechanistic rationale: visual angiography notoriously misclassifies lesion severity in 30–40% of intermediate stenoses. A key limitation to weigh is that STEMI itself transiently alters microvascular resistance, potentially confounding physiologic measurements taken acutely. Whether guidance performed during index hospitalization versus staged procedures affects the reliability of functional indices remains an important nuance. For clinicians and patients alike, this trial is potentially practice-changing rather than merely incremental — providing a more precise framework for a decision made under acute time pressure.